AXSM Trading Analysis - 09/11/2026 04:39 PM โ€” TRU-SENTIMENT

AXSM (Axsome Therapeutics, Inc) at $220.75. True Sentiment Bullish, delta 40-60 call 61% / put 39%, call $545,900 vs put $345,590. RSI 65.7.

TRU-SENTIMENT ยท DeltaNeutral

AXSM Trading Analysis - 09/11/2026 04:39 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

AXSM (Axsome Therapeutics, Inc) at $220.75. True Sentiment Bullish, delta 40-60 call 61% / put 39%, call $545,900 vs put $345,590. RSI 65.7.

Symbol
AXSM
Price
$220.75
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-09-11 16:39:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume:

  • Call dollar volume: $545,900
  • Put dollar volume: $345,590

The options flow sentiment is bullish, indicating that investors are expecting the stock price to increase in the near term.

Key Statistics: AXSM

$211.12 +0.00%
52-Week Range
$112.90 - $260.19
Market Cap
$21.50B
P/E (TTM)
-56.45
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$685,116
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)-56.45
P/E (Forward)N/A
PEG RatioN/A
Price/Book258.04

Profitability

EPS (Trailing)$-3.74
EPS (Forward)N/A
ROE-230.05%
Net Margin-24.68%

Financial Health

Revenue (TTM)$776.57M
Debt/Equity8.14
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for AXSM include:

  • Axsome Therapeutics Announces Commercial Availability of Zoloft (Sertraline) in the US (Source: Company Press Release)
  • Axsome Therapeutics Reports Q2 2026 Financial Results and Provides Business Update (Source: Company Press Release)
  • AXSM Stock Surges on Positive Phase 3 Trial Results for Novel Therapeutic Agent (Source: MarketWatch)

These headlines suggest that AXSM has been experiencing significant developments in its business, including commercial availability of new products and positive trial results. These catalysts could impact the stock's price action and sentiment.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Total Revenue: $776,569,000
  • Trailing EPS: -$3.74
  • Trailing P/E: -56.45
  • Price-to-Book: 258.04
  • Debt-to-Equity: 8.14
  • Return on Equity (ROE): -2.30%
  • Operating Margins: -23.96%
  • Profit Margins: -24.68%

The fundamentals indicate that AXSM has a significant debt-to-equity ratio and negative profit margins, which could be a concern for investors. However, the company's revenue growth and EPS trends are not provided, making it difficult to assess the company's long-term prospects.

Current Market Position:

Current price: $220.75

Recent price action: The stock has been trending upward, with a significant increase in price over the past few days.

Key support and resistance levels:

  • Support: $210.63 (9/9 close)
  • Resistance: $229.62 (intraday high on 9/11)

Technical Analysis:

SMA trends:

  • SMA 5: $211.40
  • SMA 20: $208.98
  • SMA 50: $221.40

RSI (14): 65.65 (mildly overbought)

MACD: -2.43 (slightly bearish)

Bollinger Bands:

  • Middle: $208.98
  • Upper: $220.32
  • Lower: $197.63

The technical indicators suggest that the stock is mildly overbought, but the MACD is not showing a clear bearish signal. The Bollinger Bands indicate that the stock is trading near the upper band, which could be a resistance level.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume:

  • Call dollar volume: $545,900
  • Put dollar volume: $345,590

The options flow sentiment is bullish, indicating that investors are expecting the stock price to increase in the near term.

Key Price Levels:

  • Support: $210.63
  • Resistance: $229.62
  • Entry: $215.00
  • Target: $225.00
  • Stop Loss: $205.00

25-Day Price Forecast:

AXSM is projected for $225.00 to $240.00

The forecast is based on the current technical trends, momentum, and indicators. The stock has been trending upward, and the RSI and MACD indicators suggest that the stock has further upside potential.

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three defined risk strategy recommendations:

  • Bull Call Spread: Buy 1 AXSM 261016C00220000 (220.0) and Sell 1 AXSM 261016C00240000 (240.0)
  • Bear Put Spread: Buy 1 AXSM 261016P00220000 (220.0) and Sell 1 AXSM 261016P00200000 (200.0)
  • Iron Condor: Sell 1 AXSM 261016C00220000 (220.0) and Buy 1 AXSM 261016C00240000 (240.0), Sell 1 AXSM 261016P00200000 (200.0) and Buy 1 AXSM 261016P00220000 (220.0)

These strategies have a defined risk and reward profile, and they can be used to profit from the expected price movement of AXSM.

Risk Factors:

  • Technical warning signs or weaknesses: The stock is mildly overbought, and the MACD is not showing a clear bearish signal.
  • Sentiment divergences from price action: The options flow sentiment is bullish, but the technical indicators are not showing a clear bullish signal.
  • Volatility and ATR considerations: The ATR is 6.77, indicating that the stock has been experiencing significant price movements.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: Medium

One-line trade idea: Buy AXSM with a target price of $225.00 and a stop loss at $205.00


View AXSM Options Chain

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.